Granzyme B (gzmB) of cytotoxic T lymphocytes (CTL) is essential for recovery from intracellular pathogens, but the molecular basis of its action is still unresolved. Here, we analyzed gzmB-mediated death pathways under physiological conditions using ex vivo virus-immune CTLs that express perf and gzmB, but not gzmA (gzmB þ CTL). We show that gzmB þ CTL abrogate target cell proliferation most likely by inducing cell death, independent of caspases and mitochondrial signaling. In addition, the data reveal that gzmB þ CTL independently induce pro-apoptotic processes either via caspase-3/-7, leading to plasma membrane perturbance and ROS production or via Bid/Bak/Bax, resulting in cytochrome c release and that both pathways elicit loss of DW m . Our data provide evidence for a pleiotropic pro-apoptotic function of gzmB presumably to counteract evasion strategies of pathogens and to control tumors.
Induction of programmed cell death (apoptosis) is a critical process in the host defense against intracellular pathogens and tumors. Natural killer (NK) cells and cytotoxic T lymphocytes (CTLs) are the main players in these processes. 1 NK/CTL-induced apoptosis of infected or transformed target cells is mediated by the cytoplasmic granule components perforin (perf) and two abundant serine proteinases with highly distinct and restricted proteolytic activities, i.e. granzyme (gzm) A and gzmB. 2, 3 Previous studies have shown that gzmA and gzmB, when administered intracellularly together with perf, are able to induce, independently, various proapoptotic processes associated with target cell death. 4, 5 By employing purified gzmA/gzmB or CTL from mice deficient in gzmA and/or gzmB, it was demonstrated that mitochondrial damage is a key step in gzmA-and gzmB-induced apoptosis [4] [5] [6] but that caspase activation only occurs in the presence of gzmB. 4, 6, 7 Once released into the cytoplasm, gzmB was proposed to act via two mechanisms to trigger pro-apoptotic events: (1) to activate the effector caspase-3 by proteolytic processing 8 and (2) to bypass caspase-3 activation and directly cleave cellular substrates implicated in the execution and/or morphology of apoptosis. 12 For the first mechanism, gzmB-activated caspase-3 cleaves dozens of cellular substrates, including the inhibitor ICAD which, upon degradation, releases the active endonuclease CAD for intranucleosomal degradation. In addition, active caspase-3 was shown to indirectly induce reactive oxygen species (ROS) production by targeting the p75 subunit of respiratory chain complexes I and II in previously permeabilized mitochondria. 9 Through the action of cytosolic NADPH oxidase, active caspase-3 can also induce hydrogen peroxide and ROS production independent of mitochondria. 10 Finally, caspase-3 activation by gzmB seems to be a key factor for the exposure of phosphatidylserine (PS) on the cell surface, one of several 'eat-me' signals for effective phagocytosis of apoptotic vesicles 11 as well as for the cellular uptake of propidium iodide (PI) due to increased plasma membrane permeability. 6, 8, 12 Other caspases such as caspase-2, -6, -7, -8, -9 and -10 have been reported to serve as direct or indirect targets of gzmB, but may amplify/enhance rather than trigger CTL-mediated apoptosis. 13 For the second mechanism, gzmB was found to directly cleave a number of structural and regulatory proteins of the cytoskeleton, cytosol and nucleus. 4, 5, 8, [14] [15] [16] [17] This constitutes a caspase-independent gzmB trigger of CTL-mediated cell death, but the contribution of each substrate cleavage event to cell death remains poorly defined. A notable exception is the BH3-only protein Bid. This protein, belonging to the Bcl-2 family of apoptosis regulators, can either be processed to truncated Bid (tBid) by caspase-8 in the death-receptor signaling pathway 18 or, at an alternative cleavage site, by gzmB during CTL-mediated cell death. 8, 17 tBid is known to translocate to mitochondria where it activates Bax and/or Bak, two pro-apoptotic members of the Bcl-2 family that mediate increased mitochondrial membrane permeability and the release of apoptogenic factors, such as cytochrome c, apoptosis-inducing factor (AIF) and endonuclease G (endoG) from the intermembrane space into the cytosol. 19 While the latter two factors trigger caspase-independent death signaling pathways, cytochrome c binds to Apaf-1 and recruits caspase-9 into a high molecular weight heptameric structure called the apoptosome, which is then responsible for activating effector caspase-3 and -7. In contrast to the direct processing and activation of caspase-3, this tBid/Bax/Bakmediated mitochondrial pathway would be an indirect mode of action of gzmB to activate caspase-3 and -7.
At present, there is some controversy regarding the interplay of these two modes of actions of gzmB as well as the exact order of the events triggered by this protease during CTL-mediated apoptosis. The main focus of research has been directed toward mechanisms of how gzmB initiates mitochondrial damage. One pathway is thought to involve the direct action of gzmB on mitochondria to provoke suppression of mitochondrial transmembrane potential (DC m ) and increased ROS production without the release of apoptogenic factors such as cytochrome c. 20 Another pathway was shown to require gzmB-mediated Bid cleavage to release cytochrome c as well as to trigger DC m loss and/or ROS production. 17 Moreover, for the concomitant induction of AIF and endoG release from mitochondria by gzmB and a sustained DC m loss, additional activation of caspases seems to be required. 12 Finally, others have suggested that neither Bid nor Bak and Bax are necessary for initiating mitochondrial perturbation, 7, 21 but that caspases 21 or other cytosolic factors 7 are needed. Recent evidence from caspase-3/-7 double knockout cells has lent support to the notion that effector caspases can be critical mediators of mitochondrial events during apoptosis, 22 but it has remained enigmatic to what extent they play a role in gzmB-initiated mitochondrial signaling leading to cell death. 17, 21 The major hurdle for dissecting the molecular actions of gzmB during CTL-mediated cell death has been the use of artificial in vitro or semi-intact cellular systems with purified gzmB, gzmA and perf preparations rather than cell-based CTL assays. Here, we have used physiological conditions namely ex vivo virus-immune CTLs that express perf and gzmB, but not gzmA (gzmB þ CTL) or any other functionally active gzm to reevaluate the pro-apoptotic potential of gzmB under more physiological conditions.
Results
Experimental system. CTLs were ex vivo-derived virusimmune CD8 þ T cells from gzmA À/À mice 8 days after lymphocytic choriomeningitis virus (LCMV) infection. These cells express perf and gzmB but not gzmA (gzmB þ CTL; Supplementary Figure S1 ). As target cells we used mouse embryonic fibroblasts (MEFs) derived from wild-type (MEF.wt) and knockout (ko) mutant mice with deficiencies of either, Bid (MEF.Bid Figure S1a) . The levels of gzmB were also roughly the same in gzmB þ CTL, B6 CTL and perf À/À CTL and not detectable in gzmA Â B À/À CTL (Supplementary Figure S1b ). All four ex vivo CTL populations, independent of their genotype, expressed gzmK transcripts, but lacked mRNA for gzmC, D, E, F, G and M, with the exception of perf À/À CTL, which expressed low levels of gzmC transcripts (Supplementary Figure S1d) . gzmB þ CTLs have a similar potential as B6 CTL to induce cell death (Pardo et al. 6 and data not shown), loss of plasma membrane integrity (monitored by exposure of PS at the plasma membrane and incorporation of PI) and severe mitochondrial perturbation (monitored by reduction of the DC m and increase in the generation of ROS) when tested on gp33-pulsed MEF.wt cells (Supplementary Figure S2a, b) . These data indicate that CTL/target cell interaction and subsequent exocytosis is normal in gzmB þ CTL. They also confirm previous results with EL4 target cells 6 showing that CTL-induced loss of plasma membrane and mitochondrial integrity as well as cell death is readily elicited by gzmB in the absence of gzmA. In contrast to gzmB þ CTL, both gzmA Â B À/À and perf Figure S3c; and Pardo et al. 6 ). However, all three CTL populations were similarly able to mobilize Lamp-1 to the cell surface after incubation with gp33-labeled MEF.wt cells (Supplementary Figure S3d) . These data exclude any contribution from additional proteases, including gzmK (transcripts expressed in all wt and gzmA/B ko strains; see above), to the pro-apoptotic activities of gzmB þ CTL and suggest that the intracellular processes induced by gzmB þ CTL in MEF.wt cells, including cell death, are exclusively due to gzmB.
As different MEF targets were used, we determined whether all mutant MEFs had the same ability as MEF.wt cells to induce degranulation of gzmB þ CTL upon antigen recognition. For this purpose, degranulation of gzmB þ CTL was determined by monitoring expression of the lysosomal marker Lamp-1 on their plasma membrane, following incubation with MEF.wt cells in the presence or absence of gp33. As shown in Supplementary Figure S1c , similar expression levels of Lamp-1 were seen in gzmB þ CTL after incubation with any of the gp33-pulsed, but not mock-treated MEF lines.
Bid and Bak/Bax are critical for gzmB þ CTL-induced cytochrome c release, but not for plasma membrane perturbation, mitochondrial depolarization or target cell killing. We first tested which of the pro-apoptotic effects induced by gzmB þ CTL are governed through the Bid/Bak/ Bax-mediated mitochondrial axis in our experimental system. As shown in Figure 1 , PS exposure and PI incorporation (Figure 1a In contrast, while the release of cytochrome c was readily detected in MEF.wt, it was almost completely absent in MEF.Bid À/À or MEF.Bak Â Bak À/À cells ( Figure 3a ). This process was independent of caspase-3, -7 and -9 as the gzmB þ CTL-mediated release of cytochrome c was reduced neither in MEF.wt cells pretreated with the pan-caspase inhibitor Ac-ZVAD-fmk (Supplementary Figure S4a) nor in MEF.Casp 3 Â 7 À/À or in MEF.Casp 9 À/À cells ( Figure 3b ). These data indicate that Bid and Bak/Bax are critical for gzmB-induced cytochrome c release, but not for ROS production, suppression of DC m , perturbation of the plasma À/À cells were incubated with ex vivo virus-immune gzmB þ CTL at different effector/target ratio (4 h) in the presence or absence of the general caspase inhibitor Ac-ZVAD-fmk (80 mM). Target cell death was monitored by survival assay as described in Materials and Methods. Representative of two independent experiments. Ctr: only target cells; ctr ZVAD: target cells þ ZVAD-fmk membrane and, most surprisingly, cell death. Our finding supports some previous work where purified gzmB was used to measure plasma and mitochondrial membrane perturbation, 7, 21 but apparently contradicts those data obtained with Bid-deficient cells where resistance to gzmBmediated cell death was shown. 23 The role of Bid and Caspase-3 and -7 are activated by gzmB þ CTL, independently of Bid, Bax and Bak but neither of the two enzymes are required for gzmB þ CTL-mediated target cell death. Next, we determined whether effector caspase-3 and -7 were activated and/or required for gzmB þ CTL-mediated cell death of gp33-pulsed MEFs. For that purpose, gzmB þ CTLs were incubated with MEF.wt cells previously treated with either the general caspase inhibitor Ac-ZVAD-fmk, the more caspase-3/-7 selective inhibitor Ac-DEVD-fmk or with MEF.Casp 3 Â 7 À/À cells; untreated MEF.wt cells served as a control.
Similar to previous findings with EL4 thymoma cells as targets, 6 the treatment of MEF.wt cells with Ac-ZVAD-fmk did not prevent target cell death by gzmB þ CTL (Figure 2a ). This was also the case when MEF.Bid À/À and MEF.Bak Â Bax (Figure 2c ). These data suggest that gzmB-induced target cell death occurs primarily through a caspase-independent mechanism.
To determine if caspase-3 was nevertheless activated in the gp33-pulsed MEF.wt cells upon gzmB þ CTL gzmB þ CTL-induced activation of caspase-3 and -7 is needed for PS surface exposure and plasma membrane permeability. The question remained for what purpose, if not cell death, caspase-3 was activated in the gp33-pulsed target cells in response to gzmB þ CTL incubation. We therefore first tested the contribution of caspases in general and caspase-3 and -7 in particular in gzmB þ CTL-induced PS exposure and plasma membrane permeability. Figure 4b shows that when Ac-ZVAD-fmk was added to gp33-pulsed MEF.wt cells incubated with gzmB þ CTL, the percentages of annexin-V þ and PI þ target cells were drastically reduced as compared to untreated cells as shown previously. 6 A similar result was obtained with gzmB þ CTL-treated MEF.Casp 3 Â 7 À/À cells, while MEF.wt cells showed a marked increase in PS exposure and PI permeability (Figure 5a ). Using MEF.Casp 3 À/À and MEF.Casp 7
À/À cells to analyze the individual roles of caspase-3 and -7 in this process, we noted a synergistic effect of caspase-3 and -7 ( Figure 5c) ; remarkably, caspase-7 was able to replace caspase-3 in inducing membrane damage. In contrast, caspase-9, a caspase-3-activating initiator caspase of the mitochondrial pathway, did not play any role in these effects as MEF. Casp 9 À/À cells were indistinguishable from MEF.wt (Figure 5a ). These data extend previous findings by us and others showing that caspase-3 activation results in surface exposure of PS and increased plasma membrane permeability. 6, 8, 12 However, these results suggest that gzmB þ CTL-induced PS exposure on target cells does not depend on mitochondrial signaling (Bax/Bak activation, cytochrome c release, caspase-9 activation), at least at early stages of CTL-target cell interaction (4 h), and are not required for final gzmB þ CTL-induced target cell killing (see above, Figure 2a and b) . gzmB þ CTL-induced activation of caspase-3 and -7 but not caspase-9 is needed for ROS production, but not for the loss of the mitochondrial membrane potential . We next tested the role of caspase-3, -7 and -9 in gzmB (Figure 1f) , the data indicate that gzmB is able to induce two independent pathways of mitochondrial depolarization: one mediated by Bid-dependent Bak/Bax (Figure 5b ) and the other by activation of both caspase-3 and -7, and independent of Bid/Bak/Bax (Figure 1b and d) . Only when both pathways are simultaneously inhibited, then the integrity of mitochondria from gzmB-challenged target cells is maintained. However, gzmB þ CTL-mediated cell death still occurs under the latter conditions, as revealed by a cell survival assay (Figure 2a) .
Discussion
The multitude of independent and/or interconnecting proapoptotic pathways, which have been described so far renders it difficult to define a general model of gzmB-induced cell death. This may in part be due to the fact that gzmB proteins, CTLs and target cells from different species have been used interchangeably, but they in fact exhibit distinct qualities. [24] [25] [26] In addition, the substrate specificity of gzmB in cell-free systems may be different from those of intact cells.
The present study was designed to analyze pro-apoptotic processes induced by native mouse gzmB under physiological conditions, by using ex vivo-derived, virus-immune mouse gzmB þ CTL as a source of gzmB, wt and mutant MEFs as target cells and low effector to target cell ratios (E:T ¼ 10:1). The data show that gzmB induces plasma membrane damage by a caspase-3 or -7-dependent pathway, but independently of mitochondrial signaling (Figure 7 ). The same is true for gzmB-mediated ROS production. However, gzmB induces mitochondrial perturbation by two distinct processes, one involving caspase-3 and/or -7 independently of Bax/Bak to trigger loss of DC m and ROS production, and the other engages Bid and Bak Â Bax in the absence of caspase activation to provoke loss of DC m and cytochrome c release (Figure 7) . The additional finding that gzmB þ CTL abrogates target cell proliferation, most likely by inducing cell death, even upon inhibition of both, caspases and mitochondrial events, suggests additional cytosolic targets that mediate gzmB-induced cell death and emphasizes the pleiotropic proapoptotic potential of gzmB.
Genetic and functional analyses indicate that gzmB is the only protease contributing to the gzmB þ CTL-mediated proapoptotic and cytolytic activities observed. Although all ex vivo-derived virus-immune CTLs expressed transcripts for gzmK the putative protein did not act by itself, as gzmA Â B À/À CTL, which expressed perf and gzmK transcripts, but neither gzmA, gzmB or any of the other gzms, including C, D, E, F and M, were able to induce any of the pro-apoptotic processes analyzed or to cause cell death under similar conditions (Supplementary Figure S1d; 3a-c; and Pardo and colleagues 6,27 and Revell et al. 28 ). This contrasts with a recent report which suggests that gzmA Â B À/À CTLs are able to induce, at least to some limited extent, cell death and proapoptotic processes, such as PS translocation, by mechanisms distinct from classical apoptosis. 29 This discrepancy may be due to the fact that the latter studies employed in vitropropagated rather than ex vivo CTL, and that in vitrocultivated CTLs express different patterns of gzms, including gzmC (Revell et al. 28 and own unpublished results), distinct from those seen in ex vivo-derived LCMV-immune gzmB þ CTL. The data obtained with ex vivo-derived LCMVimmune perf À/À and gzmA Â B À/À CTL also exclude a contribution of the FasL/Fas system to gzmB þ CTL-mediated pro-apoptotic processes, including cell death, of MEFs observed.
The notion that caspases, in particular caspase-3, are critical for gzmB-induced plasma membrane disturbance 6, 8 is substantiated by our finding showing that gzmB þ CTL did not induce PS exposure in caspases-3/-7-deficient MEFs. In addition, we show for the first time that caspase-7 can replace caspase-3 in this gzmB-mediated process and that both enzymes synergize in the pro-apoptotic program. The fact that gzmB induced similar levels of PS exposure in MEF.wt, MEF.Bid
À/À and MEF.Casp 9 À/À cells, also suggests that activation of caspase-7, like caspase-3, 13 is an early event in target cell apoptosis and independent of mitochondrial events, including cytochrome c release and subsequent caspase-9 activation. In light of a recent report showing that caspase-7 is more sensitive to proteolysis by gzmB compared to caspase-3, 13 we postulate an important role for caspase-7 in the early phase of CTL-mediated membrane disturbance via gzmB. Although the putative caspase-7 substrate(s), critical for this process, has not yet been identified it is possible that caspase-7, like caspase-3, contributes to plasma membrane blebbing by cleaving the actin remodeling protein gelsolin. 30, 31 Alternatively, caspase-7 or other caspases may synergize with gzmB in targeting and perturbing the cytoskeleton by cleaving a-tubulin, the tubulin folding cofactor and/or other relevant proteins, such as filamin and ROCKII. 14, 15, 32 However, the data do not exclude the Figure 7 Model for gzmB-mediated pro-apoptotic pathways and cell death elicited by ex vivo CTL. gzmB exerts pleiotropic pro-apoptotic potential in gzmB þ CTL-induced cell death. First, gzmB directly activates caspase-3 and -7, independently of mitochondrial events such as Bid-induced Bak/Bax activation and cytochrome c release. Caspase-7 can replace caspase-3 in the induction of plasma membrane perturbance (PS exposure and PI permeability), and both caspases are critical in gzmB-mediated ROS production. However, both processes are dispensable for gzmB þ CTL-mediated cell death. Second, gzmB-induced activation of Bid and Bak/Bax is independent of caspase-3 and -7 and leads to cytochrome c release. The absence of Bid or Bak/Bax does not interfere with gzmB þ CTLinduced cell death. Third, gzmB-mediated mitochondrial perturbation is triggered by two distinct pathways, one involving Bid/Bax/Bak, independent of caspases, to induce DC m loss and cytochrome c, and one triggering caspase-3/-7 activation without the implication of Bid/Bax/Bak to induce DC m loss and ROS production. Only when both pathways are simultaneously blocked, mitochondrial depolarization is prevented. Finally, gzmB kills target cells independent of caspases and mitochondrial signals, including PS exposure, mitochondrial depolarization, ROS production and cytochrome c release possibility that gzmB þ CTL-induced and caspases-3/-7-facilitated PS exposure is modulated by additional processes, including mitochondrial events, under different conditions. Different CTL population may express or deliver different amounts of gzmB causing target cells to enter distinct pathways of apoptosis.
The observation that gzmB þ CTL induced ROS production in MEF.wt, MEF.Bid À/À and MEF.Bak Â Bax À/À cells, but not in MEFs deficient in caspase-3, -7 or both, is novel. It suggests that a concerted action of the two caspases is required in ROS production and independent of Bax/Bak, but not necessarily caspase-mediated mitochondrial membrane perforation. This extends previous findings which showed that caspase-3 induces ROS production by targeting the p75 subunit of respiratory chain complexes I and II in previously permeabilized mitochondria. 9 However, our data are at variance with a recent report showing that purified rat gzmB triggered ROS production from isolated mouse mitochondria, even in the absence of the cytosolic S100 fraction. 20 Although unclear at present, this discrepancy may be due to the fact that gzmB and mitochondria were derived from different species. The combined data, however, indicate that mouse gzmB, when delivered via CTL is unable to directly target mitochondria and reveal caspase-3 and -7 as the main executors during gzmB þ CTL-induced ROS production. Our data do not discriminate whether gzmB þ CTL-induced ROS only derives from mitochondria, in particular by interference of caspase-3 with the electron transport chain, as suggested before 9 or from other sources, such as peroxisomes, the cytosolic NADPH oxidases or cytochrome P-450 enzymes in the endoplasmic reticulum. Future studies will have to identify the exact intracellular source of ROS during gzmB-dependent target cell killing. gzmB þ CTL similarly induced DC m loss in both MEF.Bid
and MEF.Bak Â Bax À/À , and in MEF.Casp 3 Â 7 À/À cells, indicating that gzmB triggers two independent pathways resulting in mitochondrial depolarization. These data corroborate, at least partially, previous studies 7, 8, 17, 21 and suggest that gzmB elicits DC m loss either via Bid cleavage and subsequent activation of Bak/Bax or by engaging caspase-3 and -7.
The pro-apoptotic events, which accompany the loss of DC m by these two pathways, are however distinct: whereas the Bid/Bad/Bak-dependent pathway involves cytochrome c release, the caspase-3/-7-dependent one is accompanied by ROS production. Interestingly, both pathways appear to be redundant for gzmB þ CTL-induced apoptosis, since both have to be blocked to rescue cells from DC m loss. The additional finding that gzmB þ CTL did not induce DC m loss and ROS generation in MEF.Bid À/À or MEF.Bak Â Bax À/À cells, whose caspases were inhibited by Ac-ZVAD-fmk or Ac-DEVD-fmk, excludes the possibility that gzmB modulates DC m by other, yet unidentified cytosolic and/or mitochondrial proteins as previously suggested by using recombinant mouse gzmB and MEF cells. 7 Although this discrepancy has not been resolved, two reasons may be responsible for it; the use of purified gzmB versus ex vivo CTLs and/or the effect of additional factors in the LAK extracts used, as the perf source to deliver gzmB. 7 gzmB þ CTL-induced cytochrome c release was absent in Bid-or Bak Â Bax-deficient MEFs, but proceeded normally in cells lacking caspase-9 or caspase-3, -7 or both. This finding supports previous studies showing that gzmB induces mitochondrial outer membrane permeabilization, via direct cleavage of Bid instead of activating caspase-3, leading to Bak/Bax activation and subsequent release of pro-apoptotic proteins such as cytochrome c from the mitochondrial intermembrane space. 8, 12 An alternative pathway has been proposed by which gzmB cleaves the survival factor Mcl-1 to release its BH3-only partner Bim 33 with subsequent activation of Bak/Bax. The strict dependence of cytochrome c on Bid in our study excludes, however, a role for Bim as Bak/Bax activator in this gzmB þ CTL-mediated process. The relationship between gzmB-mediated activation of caspases and mitochondrial events, in particular the differential interdependence of Bid and caspase-3 in these processes, has been a matter of controversy. 17, 21 Our results obtained with a physiologically relevant gzmB þ CTL-target cell system clearly demonstrate that gzmB can do both, readily induce caspase-3/-7 activation and subsequently cause plasma membrane perturbation and ROS production independently of Bid, Bax or Bak (in MEF.Bid À/À and MEF.Bak Â Bax À/À cells) as well as use Bid cleavage and Bax/Bak activation to induce cytochrome c release in the absence of caspase-3/-7 activation (in MEF.Casp 3 Â 7 À/À cells). The latter finding supports data by some 7, 8, 17 but contradicts other studies, which showed that cytochrome c release by gzmB was inhibited by the caspase inhibitor Z-VAD-fmk. 34, 35 The most novel finding of our study was that gzmB þ CTLabrogated target cell proliferation, most probably by inducing cell death, as monitored by cell survival assays, occurs in the absence of mitochondrial damage (i.e. Bax/Bak activation) and activation of caspases. This result is consistent with and extends our previous study showing that gzmB þ CTLmediated cell death could neither be inhibited by the general caspase inhibitor Ac-ZVAD-fmk nor the antioxidant agent NAC. 6 Whether this type of gzmB-induced abrogation of cell proliferation or cell death is characterized by apoptotic or necrotic features, or by both, and whether this pathway of cell arrest or death is of advantage in host defense against pathogens is not yet known and requires further experimentation. However, the fact that one of the early pro-apoptotic feature, i.e. plasma membrane disturbance, including PS exposure, is not observed in target cells that die independently of caspases suggests that they are refractory to elimination by phagocytosis via the PS receptor 11 and may hence induce pathological processes in vivo.
The finite genetic space available to the host for its immune defense requires enormous plasticity in its effector function to encompass all the evasion strategies of the multitude of pathogens. The immune system has achieved this in its recognition phase by generating diversity by genetic means of recombination and somatic mutation. Effector mechanisms, such as cytotoxicity leading to cell death via apoptosis, on the other hand have greater constraints in expressing plasticity. One way in possibly achieving diversity of effector function is by generating multiple distinct death pathways employing a limited number of effector molecules.
The data presented here provide evidence that mouse gzmB, one of the important effector molecules of CTL and NK cells, can function via a multitude of pathways all leading to cell death. This plasticity is most likely the result of evolutionary pressures from pathogens trying to evade immune elimination, including cellular cytotoxicity. One example being poxvirus-encoded serine protease inhibitors that can severely curtail cytolytic effector functions, most probably by inhibiting Fas-mediated and caspase-facilitated PS exposure, resulting in uncontrolled viral spread. 36 This diversity in effector function of cytolytic pathways will also be to the host's benefit in tumor elimination.
Finally, our data provide evidence that conclusions drawn from experimental results employing more reductionist approaches (i.e. using recombinant enzymes in artificial in vitro settings) may be erroneous in biological context.
Materials and Methods
Mouse strains. Inbred B6, and mouse strains deficient for perf (perf
) and gzmA Â B (gzmA Â B À/À ), bred on the B6 background were maintained at the Max-Planck-Institut für Immunbiologie, Freiburg and analyzed for their genotypes as described. 6 Male mice of 8-10 weeks of age were used in all experiments and were performed in accordance with the local animal care commission.
Generation of ex vivo CD8
þ cells. Mice were infected with 10 5 p.f.u. LCMV-WE i.p. according to established protocols. 6 On day 8 postinfection, CD8 þ cells were positively selected from spleen using a-CD8-MicroBeads (Miltenyi Biotec, Bergisch Gladbach, Germany) with an autoMACS (Miltenyi Biotec) and resuspended in MEM/5% FCS prior to use in cytotoxic assays. Purity of selected CD8 þ cells was assessed by FACS staining and found to be between 95 and 98%.
Cell lines, cell culture and reagents. SV40-transformed MEFs were cultured in MEM supplemented with 10% FCS and 2-mercaptoethanol (10 À5 M) at 371C, 7% CO 2 . Bid À/À and Bax À/À Â Bak À/À MEFs were generated and generously provided by the SJ Korsmeyer laboratory and compared to an MEF.wt cell line, generated by the same group. À/À and Casp 3 Â 7 À/À MEFs were generated by the group of Richard A Flavell 22 and compared to an MEF.wt cell line generated by the same group. The genotype of the various MEF cells was periodically tested by genomic PCR and western blot analysis. In some cases, the general caspase inhibitor Ac-ZVAD-fmk or the caspase-3/-7 inhibitor Ac-DEVD-fmk (Bachem; 100 mM both) were added to cell cultures as described. 6 The mouse cell lines 1.3E6 (CTL) and EL4.F15 (EL4) were cultured as described. 37 RT-PCR. Total RNA was extracted from up to 5 Â 10 6 cells, using the QIAshredder spin columns, the RNeasy Mini Kit and the RNase-free DNase Kit (all from Qiagen, Hilden, Germany) according to the manufacturer's instructions, and specific transcripts were amplified. The sense/antisense primers for gzmA and Hprt1 and gzmC, gzmD, gzmE, gzmF and gzmG are described in Martin et al. 37 Flow cytometry. Cell populations were analyzed for cell surface marker expression, pentamer staining and/or intracellular expression of gzmA and gzmB by FACS as described. 37 In all cases, cells were incubated with anti(a)-FcR-antibody (clone 2.4G2) prior to the first staining step. Detection of LCMV-immune CTL was conducted by staining MACS-selected CD8 þ T cells with gp33-labeled pentamers (H-2D b pent-PE). Rabbit immune serum (IS) specific for mouse gzmA (a-mgzmA) has been described. 37 Rabbit a-mouse gzmB (a-mgzmB) IS was generated by repeated immunization of rabbits with pro-rec.gzmB as described for a-mgzmA IS.
Lamp-1 mobilization assay. Lamp-1 (CD107a) expression in the cell membrane of ex vivo CTLs was analyzed as described. 38 Briefly, MEF cells were pretreated with the LCMV-immunodominant peptide gp33 for 2 h prior to incubation with ex vivo-derived LCMV-immune CTL at 2:1 E:T cell ratio (triplicates, 4 Â 10 4 targets and 8 Â 10 4 CTLs/well). Subsequently, the mixed cell population was treated with 1 ml (final dilution 1:200) of a-Lamp-1-FITC antibody (BD Pharmingen) in the presence of monensin for 6 h at 371C, 7% CO 2 . Non-attached cells were collected, labeled with a-CD8-APC antibody and analyzed by FACS.
Analysis of pro-apoptotic processes. Cell death induced by ex vivo CTL in MEF cells was analyzed as described. 6 MEF cells were pretreated with the LCMV-immunodominant peptide gp33 for 2 h prior to incubation with ex vivo-derived LCMV-immune CTL at 10:1 E:T cell ratio for 4 h at 371C, 7% CO 2 . 6 Subsequently, different apoptotic parameters were tested in the target population (CD8 À ) by FACS with a FACScan (BD Pharmingen) and CellQuest s software as follows: Cell membrane and mitochondrial membrane perturbations: PS exposure and PI uptake were analyzed by FACS as described 6 using the annexin-V-FITC kit from BD Pharmingen. The mitochondrial membrane potential was measured with the fluorescent probe 3,3 0 -dihexyloxacarbocyanine iodide (DiOC 6 (3); Molecular Probes) and ROS generation with 2-hydroxyethidium (2-HE; Molecular Probes) as described.
Survival assays. Survival of target cells following their incubation with CTL was analyzed as described. 27 This assay gives similar results to clonogenic survival assay in agar plates (AM, unpublished observations). Accordingly, MEF cells were pretreated with the LCMV-immunodominant peptide gp33 (2 h) prior to incubation with ex vivo-derived LCMV-immune CTLs at 10:1 E:T cell ratio for 4 h. Wells were washed once with MEM plus 2% FCS to remove non-adherent cells and attached cells were resuspended in MEM plus 2% FCS. No viable cells were detected among the non-adherent cells. Target cell survival was quantified by
